Lantern Pharma

LTRNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$36.490 M

$2.86 +2.88%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$17.1M

Loss-making

Shares outstanding

11,254,697

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#365VeruVERU$37.4M
#366ApollomicsAPLM$37.1M
#367Lantern PharmaLTRN$36.5M
#368NanoviricidesNNVC$36.1M
#369Serina TherapeuticsSER$36.0M

Where these numbers come from

Share counts and financials for Lantern Pharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.